Citation Impact
Citing Papers
Transcriptional Switch of Dormant Tumors to Fast-Growing Angiogenic Phenotype
2009
Genetic and Functional Studies Implicate HIF1 α as a 14q Kidney Cancer Suppressor Gene
2011 StandoutNobel
Endocan Elicits Severe Vascular Inflammatory Responses In Vitro and In Vivo
2014
Metastasis: from dissemination to organ-specific colonization
2009 Standout
Serum Endocan Levels Are Correlated with the Presence and Severity of Coronary Artery Disease in Patients with Hypertension
2015
Cytokines in the Treatment of Cancer
2018
Genomic and proteomic profiling I: Leiomyomas in African Americans and Caucasians
2007 Standout
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 StandoutNobel
The endothelial glycocalyx: composition, functions, and visualization
2007 Standout
Systemic levels of the endothelium-derived soluble adhesion molecules endocan and E-selectin in patients with suspected deep vein thrombosis
2014
Genome-wide screening of copy number alterations and LOH events in renal cell carcinomas and integration with gene expression profile
2008
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
2020 Standout
Endocan in Cancers: A Lesson from a Circulating Dermatan Sulfate Proteoglycan
2013
Sepsis biomarkers: a review
2010 Standout
Interplay between Cdc2 Kinase and the c-Mos/MAPK Pathway between Metaphase I and Metaphase II in Xenopus Oocytes
2001
Endocan — the new endothelial activation marker independently associated with soluble endothelial adhesion molecules in uraemic patients with cardiovascular disease
2015
Dermatan sulfate: new functions from an old glycosaminoglycan
2002
Endocan: A novel inflammatory indicator in cardiovascular disease?
2015 Standout
Hepatocellular carcinoma in Txnip-deficient mice
2006
Expression and distribution of endocan in human tissues
2011
Serum endocan levels as a marker of disease activity in patients with Behçet disease
2013
Vascular endocan is preferentially expressed in tumor endothelium
2006
Endocan is useful biomarker of survival and severity in sepsis
2014
Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities
2021 Standout
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Engineering interferons and interleukins for cancer immunotherapy
2022
Interactions of Multiple Heparin Binding Growth Factors with Neuropilin-1 and Potentiation of the Activity of Fibroblast Growth Factor-2
2005
Biological roles of glycans
2016 Standout
VEGF receptor signalling ? in control of vascular function
2006 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Recent advances with liposomes as pharmaceutical carriers
2005 Standout
Advances and Challenges of Liposome Assisted Drug Delivery
2015 Standout
Small-molecule inhibitors of protein–protein interactions: progressing towards the dream
2004 Standout
Markers for Sepsis Diagnosis: What is Useful?
2006
Plasma endocan levels associate with inflammation, vascular abnormalities, cardiovascular events, and survival in chronic kidney disease
2014
Survey of the year 2003 commercial optical biosensor literature
2004
Cytokines in Cancer Immunotherapy
2017
Endocan, a new endothelial marker in human sepsis*
2006
New cancer targets emerging from studies of the Von Hippel‐Lindau tumor suppressor protein
2010 StandoutNobel
Endocan, a new invasion and angiogenesis marker of pituitary adenomas
2014
Endocan: A novel circulating proteoglycan
2014
Liposomes as nanomedical devices
2015 Standout
Fighting Cancer: From the Bench to Bedside Using Second Generation Cationic Liposomal Therapeutics
2008
Dermatan sulfate exerts an enhanced growth factor response on skeletal muscle satellite cell proliferation and migration
2003
The Effects of Arterial Blood Pressure Reduction on Endocan and Soluble Endothelial Cell Adhesion Molecules (CAMs) and CAMs Ligands Expression in Hypertensive Patients on Ca-Channel Blocker Therapy
2013 Standout
CALPAIN INHIBITORS IMPROVE MYOCARDIAL DYSFUNCTION AND INFLAMMATION INDUCED BY ENDOTOXIN IN RATS
2004
Spatial and temporal dynamics of the endothelium
2005
Molecular and cellular biomarkers for angiogenesis in clinical oncology
2007
Structural and Sequence Motifs in Dermatan Sulfate for Promoting Fibroblast Growth Factor-2 (FGF-2) and FGF-7 Activity
2004
Modes of resistance to anti-angiogenic therapy
2008 Standout
Peroxynitrite: biochemistry, pathophysiology and development of therapeutics
2007 Standout
Recent advances in the structural biology of chondroitin sulfate and dermatan sulfate
2003
Survey of the year 2001 commercial optical biosensor literature
2002
Diagnostic value of the soluble triggering receptor expressed on myeloid cells-1 in bacterial infection: a meta-analysis
2008 Standout
Peroxynitrite decomposition catalysts prevent myocardial dysfunction and inflammation in endotoxemic rats
2004
Glycosaminoglycans and their proteoglycans: host‐associated molecular patterns for initiation and modulation of inflammation
2006 Standout
Elevated serum levels of endocan in patients with psoriasis vulgaris: correlations with cardiovascular risk and activity of disease
2013
Biodegradable polymers as biomaterials
2007 Standout
Effect of CPAP on New Endothelial Dysfunction Marker, Endocan, in People With Obstructive Sleep Apnea
2015
Endocan, a novel marker of endothelial dysfunction in patients with essential hypertension: Comparative effects of amlodipine and valsartan
2014
Novel chondroitin sulfate-binding cationic liposomes loaded with cisplatin efficiently suppress the local growth and liver metastasis of tumor cells in vivo.
2002
Combination therapy in combating cancer
2017 Standout
Contributions of Amino Acid Side Chains to the Kinetics and Thermodynamics of the Bivalent Binding of Protein L to Ig κ Light Chain
2004 StandoutNobel
Effect of Non‐Surgical Periodontal Treatment on Gingival Crevicular Fluid and Serum Endocan, Vascular Endothelial Growth Factor‐A, and Tumor Necrosis Factor‐Alpha Levels
2016
Endocan Levels in Peripheral Blood Predict Outcomes of Acute Respiratory Distress Syndrome
2014
Serum Endocan Level and the Severity of Coronary Artery Disease
2014
Endocan Is Upregulated on Tumor Vessels in Invasive Bladder Cancer Where It Mediates VEGF-A–Induced Angiogenesis
2012
Endocan—A Novel Inflammatory Indicator in Newly Diagnosed Patients With Hypertension
2014 Standout
Surface Plasmon Resonance Sensors for Detection of Chemical and Biological Species
2008 Standout
New B-type cyclin synthesis is required between meiosis I and II duringXenopusoocyte maturation
2001 StandoutNobel
Satellite Cells and the Muscle Stem Cell Niche
2013 Standout
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
Works of David Béchard being referenced
Activation of Xenopus Eggs by the Kinase Inhibitor 6-DMAP Suggests a Differential Regulation of Cyclin B and p39mos Proteolysis
1999
Characterization of the Secreted Form of Endothelial-Cell-Specific Molecule 1 by Specific Monoclonal Antibodies
2000
Endocan or endothelial cell specific molecule-1 (ESM-1): A potential novel endothelial cell marker and a new target for cancer therapy
2005
Endocan Is a Novel Chondroitin Sulfate/Dermatan Sulfate Proteoglycan That Promotes Hepatocyte Growth Factor/Scatter Factor Mitogenic Activity
2001
Overexpression of endocan induces tumor formation.
2003
Human Endothelial-Cell Specific Molecule-1 Binds Directly to the Integrin CD11a/CD18 (LFA-1) and Blocks Binding to Intercellular Adhesion Molecule-1
2001
IL-15 Trans-Signaling with the Superagonist RLI Promotes Effector/Memory CD8+ T Cell Responses and Enhances Antitumor Activity of PD-1 Antagonists
2016
Highly potent anti-CD20-RLI immunocytokine targeting established human B lymphoma in SCID mouse
2014